An apparatus, system and method for regulating fluid flow are disclosed. The apparatus includes a flow rate sensor and a valve. The flow rate sensor uses images to estimate flow through a drip chamber and then controls the valve based on the estimated flow rate. The valve comprises a rigid housing disposed around the tube in which fluid flow is being controlled. Increasing the pressure in the housing controls the size of the lumen within the tube by deforming the tube, therefore controlling flow through the tube.

Systems, devices, and techniques are disclosed for administering and tracking medicine to patients and providing health management capabilities for patients and caregivers. In some aspects, a system includes an injection pen device including a dose setting mechanism, a dispensing mechanism, and an electronics unit to generate dose data associated with a dispensing event of a dose of the medicine dispensed from the injection pen device and time data associated with the dispensing event; a mobile device in wireless communication to receive and process the dose data; and a software application configured to determine a recommended dose based on health data and contextual data associated with a user of the injection pen device, the software application including a learning dose calculator module to adaptively calculate the recommended dose of the medicine based on time-relevant and circumstances-relevant data specific to the user of the injection pen device.

An integrated closed-loop artificial pancreas includes: a detection module; a program module which is imported into the total daily dose algorithm and the current insulin infusion algorithm; and an infusion module which is connected to the program module. The infusion module includes an infusion tube which is used as the insulin infusion channel, the detecting electrodes are provided on/in the wall of the infusion tube, and the infusion module can infuse insulin required according to the data of the current insulin infusion dose. It takes only one insertion to perform both glucose detection and insulin infusion.

The disclosure provides a device and method for managing urinary incontinence. The device includes a platform, a balloon, and a valve. The platform and balloon can include a silicone material, a thermoplastic material, and an adhesive and/or a cement for sealing the urethra. The thermoplastic and silicone materials can soften at the body temperature so that their shape can be adapted to fit the three-dimensional contour of surfaces of the urethra. The balloon seals the internal orifice of the urethra, and the platform can block the leakage associated with the balloon. The valve permits selective urine voiding. The method includes inserting the device into the urethra and the bladder. The method can also include inflating the balloon. The method can further include pulling the balloon so that the balloon is in sealing contact with the neck of the bladder and moving the platform to a suitable position for sealing the urethra.

In one aspect, the disclosure relates to an injection device configured for expelling of a dose of a medicament. The injection device comprises a housing configured to accommodate a medicament reservoir, and a drive mechanism comprising an electric propulsion configured to mechanically interact with the medicament reservoir and configured to withdraw or to expel an amount of the medicament from the medicament reservoir. The injection device has at least a first interface directly or indirectly connected to the electric propulsion and configured to connect to a second interface of an auxiliary electronic device. The electric propulsion is controllable by the auxiliary electronic device when the first interface and the second interface are interconnected.

A waste collection system for collecting medical/surgical waste. A mobile rover includes at least one waste container supported on the mobile rover for storing the medical/surgical waste. A chassis is separate from and configured be removably coupled with the mobile rover. The chassis supports a chassis controller and a vacuum pump configured to draw a vacuum on the waste container. A rover controller is supported on the mobile rover and configured to receive a pressure signal representative of a level of the vacuum. The chassis controller is configured to be in communication with the rover controller and to regulate the level of the vacuum drawn based on the pressure signal. A transmitter may be supported on the mobile rover and in communication with the rover controller, and a receiver may be supported on the chassis to be in communication with the transmitter to establish a communication circuit for data transfer.

An ambulatory infusion pump can include a maximum bolus override procedure. When a bolus amount greater than a maximum bolus amount is requested, the pump can provide an alert indicating that the amount requested exceeds the maximum bolus amount. If the user confirms the request in response to the alert, the bolus amount can be delivered to the user. The amount delivered in response to the confirmation can be a first portion of the bolus amount. A reminder can then be provided that a second portion of the bolus amount that is a remaining portion of the requested bolus amount was also requested. If a second confirmation is received in response to the alert, the second portion of the bolus amount can also delivered to the user.

A sleep system can introduce outside stimulus such as simulated heartbeat and/or respiration to induce a response from the sleeper which can cause the sleeper's body to mimic or mate up with the delivered heartbeat and/or respiration sequence. Simulated heartbeat and/or respiration introduced to the person's sleeping environment can guide the person from an awake state to a sleeping state, help the person transition between sleep stages, help the person maintain one or more sleep stages for longer or shorter durations, and gently guide the person from an asleep state to an awake state. The simulated heartbeat and/or respiration can also improve the quality of sleep that the person experiences in a given sleep phase.

Introduced here are pressure-mitigation systems able to mitigate the pressure applied to a human body by the surface of an object (also referred to as a “structure”). A controller device (or simply “controller”) can be fluidically coupled to a pressure-mitigation device that includes a series of selectively inflatable chambers. When a pressure-mitigation device is placed between a human body and a surface, the controller can continuously, intelligently, and autonomously circulate fluid through the chambers of the pressure-mitigation device. Normally, the controller circulates air through the chambers of the pressure-mitigation device, though the controller could circulate another fluid, such as water or gel, through the chambers of the pressure-mitigation device. The controller may cause the chambers to be selectively inflated, deflated, or any combination thereof.

A self-righting device is disclosed having a support body for supporting a medicament delivery device, where the support body has a mass, a center of gravity (G) and a shape such that the self-righting device, when positioned on a substantially horizontal surface, moves from an unbalanced position to an upright position. The self-righting device can also have a mechanical adaptor configured for attachment to the support body and for holding an elongated medicament delivery device at an angle less than 30 degrees from a vertical axis when the self-righting device is in the upright position. An assembly of a self-righting device and an elongated medicament delivery device is also provided.